Scandinavian ChemoTech
2,24 SEK +1,82%Vær den første som følger denne virksomhed
Scandinavian ChemoTech is a research and development company that has developed the technology Tumor-Specific Electroporation - TSE ™ for the treatment of various cancers. The technology means that electronic pulses are sent to the treated area and the membranes of the tumor cells are opened to reach their DNA. In addition to its operations in Sweden, the company is also active in Southeast Asia and India. Scandinavian ChemoTech was founded in 2015 and is headquartered in Lund.
Omsætning
2,82 mio.
EBIT %
-717,73 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
CMOTEC B
Daglig lav / høj pris
2,1 / 2,25
SEK
Markedsværdi
40,18 mio. SEK
Aktieomsætning
6,8 t SEK
Volumen
3,1 t
Finanskalender
Delårsrapport
07.05.2024
Generalforsamling
14.05.2024
Delårsrapport
13.08.2024
Delårsrapport
05.11.2024
Årsrapport
04.03.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Försäkringsbolaget Avanza | 13,3 % | 11,2 % |
Mohan Frick (privat och genom bolag) | 12,1 % | 20,2 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Scandinavian ChemoTech's Animal Care embarks on an exciting journey along with Equitom to forge a cutting-edge Centre of Excellence
ChemoTech secures order from the largest European state-of-the-art equine (horse) clinic
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools